There appears to be a decrease in the expression levels of CTLA-4 on the surface of tumour-infiltrating CD4+ T cells post-FLOT compared with the treatment-naïve setting (p = 0.07) (Fig. 1H.). The gene discussed is CTLA4; the disease is neoplasm.